A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-09-22
Target enrollment:
Participant gender:
Summary
The aim of this trial is to confirm the efficacy of HR17031 in controlling glycaemia in Chinese subjects with type 2 diabetes mellitus inadequately controlled on oral antidiabetic agents